Research graph
References from Analysis of common differential gene expression in synovial cells of osteoarthritis and rheumatoid arthritis. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology of osteoarthritis: literature update.
10.1097/bor.0000000000000479 · 2018 · External reference
Global epidemiology of rheumatoid arthritis.
2022 · External reference
[Definition, pathology and pathogenesis of osteoarthritis]
2020 · External reference
Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee.
10.3390/ijms22052619 · 2021 · External reference
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.
2019 · External reference
Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis.
10.3389/fimmu.2021.631291 · 2021 · External reference
Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis
10.1111/cpr.13569 · 2024 · External reference
Efficacy and Mechanisms of Silybum Marianum, Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review.
2024 · External reference
[Prevalence of secondary osteoarthritis in patients with rheumatoid arthritis and risk factors for its progression].
2014 · External reference
Calcified cartilage differs in patients with end-stage primary osteoarthritis and secondary osteoarthritis due to rheumatoid arthritis of the hip joint
10.1080/03009742.2021.1952754 · 2021 · External reference
Zinc and Cadmium in the Aetiology and Pathogenesis of Osteoarthritis and Rheumatoid Arthritis.
10.3390/nu13010053 · 2020 · External reference
Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review
10.1016/j.joca.2012.08.027 · 2012 · External reference
CXCL1 contributes to IL-6 expression in osteoarthritis and rheumatoid arthritis synovial fibroblasts by CXCR2, c-Raf, MAPK, and AP-1 pathway.
10.1186/s13075-020-02331-8 · 2020 · External reference
RNA-Seq Experiment and Data Analysis.
10.1007/978-1-0716-1920-9_22 · 2022 · External reference
Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and future
10.1016/j.jbspin.2021.105164 · 2021 · External reference
Osteoarthritis.
10.1016/s0140-6736(14)60802-3 · 2015 · External reference
Effect of ambient temperature on outpatient admission for osteoarthritis and rheumatoid arthritis in a subtropical Chinese city.
10.1186/s12889-021-11994-0 · 2022 · External reference
Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature.
10.1016/j.reuma.2012.09.006 · 2013 · External reference
Influence of meteorological elements on balance control and pain in patients with symptomatic knee osteoarthritis
10.1007/s00484-016-1269-x · 2017 · External reference
A novel serological biomarker are associated with disease severity in patients with osteoarthritis
10.1007/s00774-022-01364-0 · 2022 · External reference
Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis
10.1016/j.joca.2008.12.011 · 2009 · External reference
APOD acts on fibroblast-like synoviocyte and chondrocyte to alleviate the process of osteoarthritis in vitro
10.1002/jor.25690 · 2024 · External reference
Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.
10.1016/j.semarthrit.2008.01.015 · 2009 · External reference
CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications
10.1038/s41467-023-40975-7 · 2023 · External reference
Quantitative proteomic analysis of Bi Zhong Xiao decoction against collagen-induced arthritis rats in the early and late stages
10.1186/s12906-022-03663-5 · 2022 · External reference
Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage
10.1186/s11658-022-00365-1 · 2022 · External reference
PD0325901, an ERK inhibitor, attenuates RANKL-induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathways
10.1016/j.bioorg.2022.106321 · 2023 · External reference
EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter
10.1038/s41374-021-00532-6 · 2021 · External reference
Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition
10.1016/j.bioorg.2020.103611 · 2020 · External reference
Expression of osteoclast differentiation factor in rheumatoid arthritis
10.1002/1529-0131(200011)43:11<2523::aid-anr20>3.0.co;2-z · 2000 · External reference
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
10.1002/1529-0131(200002)43:2<259::aid-anr4>3.0.co;2-w · 2000 · External reference
Signaling crosstalk between RANKL and interferons in osteoclast differentiation
10.1186/ar581 · 2002 · External reference
Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
10.1016/j.intimp.2020.107219 · 2021 · External reference
Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models
10.1016/j.clim.2023.109635 · 2023 · External reference
